Amarin Corp Plcuk (AMRN) Operating Margin Growth (5y) (2018 - 2026)

Amarin Corp Plcuk (AMRN) Operating Margin Growth (5y) (2018 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,418.00
Dec 31, 2025 6,649.00
Sep 30, 2025 -1,792.00
Jun 30, 2025 -2,505.00
Mar 31, 2025 -2,437.00
Dec 31, 2024 1,520.00
Sep 30, 2024 -5,548.00
Jun 30, 2024 172.00
Mar 31, 2024 700.00
Dec 31, 2023 10,711.00
Sep 30, 2023 774.00
Jun 30, 2023 3,148.00
Mar 31, 2023 2,969.00
Dec 31, 2022 266.00
Sep 30, 2022 1,212.00
Jun 30, 2022 -4,133.00
Mar 31, 2022 2,366.00
Dec 31, 2021 -7,949.00
Sep 30, 2021 3,786.00
Jun 30, 2021 4,915.00